Winthrop Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16
Closed -$1K 367
2025
Q3
$1K Hold
16
﹤0.01% 290
2025
Q2
$1K Hold
16
﹤0.01% 298
2025
Q1
$1K Hold
16
﹤0.01% 275
2024
Q4
$1K Buy
+16
New +$1.19K ﹤0.01% 285
2024
Q1
Sell
-16
Closed -$1.99K 187
2023
Q4
$1.99K Buy
+16
New +$1.64K ﹤0.01% 236

Other funds holding DXCM

Winthrop Capital Management's DXCM Position: Q4 2025 in Review

Winthrop Capital Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 16 shares — an estimated $1K sold.

Winthrop Capital Management first reported a position in DXCM in Q4 2023 and held it in 5 quarters. The position peaked at $1.99K in Q4 2023. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Winthrop Capital Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Winthrop Capital Management sold 16 DexCom shares in Q4 2025, an estimated $1K.
  • Winthrop Capital Management first reported a position in DexCom in Q4 2023 and held it in 5 quarters.
  • Winthrop Capital Management's DexCom position peaked at $1.99K in Q4 2023.
  • 921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Winthrop Capital Management's 13F filing for Q4 2025, filed 10 Feb 2026.